In Search of the Connection Between Depression and Addiction
Three different academic researchers examine the connection between depression and addiction.
Testing GLP-1 Drugs for Substance Use Disorders
Limited human trials of GLP-1 drugs for substance use disorders indicate they might not work well for non-obese individuals.
A New Book Makes The Case That Addiction Is Not a Brain Disease
A new book and a new brain study are raising doubts about addiction as a chronic brain condition.
Does Ozempic Cause Weight Loss By Making People Sick?
We examine anecdotal reports and scientific evidence concerning gastrointestinal discomfort as a result of taking GLP-1 drugs.
Advances in Epigenetic Editing for Addiction Treatment
Crispr and other technologies are allowing researchers to turn on and off genetic and cellular switches impacting addictive behavior.
Why Isn’t Big Pharma Investing in GLP-1 Trials for Substance Use Disorders?
There’s a noticeable lack of pharmaceutical company trials of GLP-1 drugs as treatments for substance use disorders.